The Vanguard Group 13D and 13G filings for 10x Genomics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-04 2:14 pm Purchase |
2024-09-30 | 13G | 10x Genomics, Inc. TXG |
The Vanguard Group | 10,972,930 10.300% |
1,961,598 (+21.77%) |
Filing |
| 2024-02-13 4:55 pm Purchase |
2023-12-29 | 13G | 10x Genomics, Inc. TXG |
The Vanguard Group | 9,011,332 8.650% |
591,321 (+7.02%) |
Filing |
| 2023-02-09 10:54 am Purchase |
2022-12-30 | 13G | 10x Genomics, Inc. TXG |
The Vanguard Group | 8,420,011 8.810% |
865,969 (+11.46%) |
Filing |
| 2022-02-09 3:15 pm Purchase |
2021-12-31 | 13G | 10x Genomics, Inc. TXG |
The Vanguard Group | 7,554,042 8.250% |
1,366,337 (+22.08%) |
Filing |
| 2021-02-10 10:30 am Purchase |
2020-12-31 | 13G | 10x Genomics, Inc. TXG |
The Vanguard Group | 6,187,705 7.720% |
6,187,705 (New Position) |
Filing |